Project description:MS/MS fragmentation data of Bile acid derivatives acquired on Q Exactive-with
chromatographic separation on a Phenomenex polar C18 column.
Project description:MS/MS fragmentation data of n acyl lipids acquired on Q Exactive - with chromatographic separation on a Phenomenex polar C18 column.
Project description:MS/MS fragmentation data of CDCA and Tripeptide acquired on Q Exactive - with
chromatographic separation on a Phenomenex polar C18 column.
Project description:MS/MS fragmentation data of CDCA with Tripeptide acquired on Q Exactive-with
chromatographic separation on a Phenomenex polar C18 column.
Project description:MS/MS fragmentation data of Bile acid derivatives acquired on Q Exactive - with
chromatographic separation on a Phenomenex polar C18 column.
Project description:MS/MS fragmentation data of Bile acid derivatives acquired on Q Exactive-with chromatographic separation on a Phenomenex polar C18 column.
Project description:MS/MS fragmentation data of N acyl lipids 2 acquired on Q Exactive - with chromatographic separation on a Phenomenex polar C18 column.
Project description:MS/MS fragmentation data of Bile acid derivatives was acquired on Q Exactive-with chromatographic separation on a Phenomenex polar C18 column.
Project description:MS/MS fragmentation data of bile acid conjugated with dipeptides standards acquired on Q Exactive - with chromatographic separation on a Phenomenex polar C18 column.